Summary
In cultured heart muscle cells from 10–13 day-old chicken embryos, the effects of acute (4 h) and chronic (3 days) exposure of the cells to varying concentrations of ouabain have been studied. In these cells, the cardiac glycoside ouabain binds to a specific cardiac glycoside receptor (KD=4 × 10−7 M; 750,000 receptors/cell). Binding to this receptor results in inhibition of active Na+/K+-transport [EC50 for active (86Rb+ + K+)-influx=4 × 10−6 M], and in an increase in beating velocity (“positive inotropic effect”;; EC50=4 × 10−7 M); toxic signs (arrhythmias) appear at concentrations ≥ 6 × 10−7 M. During exposure of the cells to 3 × 10−6 M ouabain for 3 days, tolerance develops with respect to both the positive inotropic and the toxic effect. The mechanism underlying this tolerance is identified as an increase in the number of active sodium pump molecules per cell, while the binding properties of the cardiac glycoside receptor remain unchanged. The development of cardiac glycoside tolerance is only observed in the presence of severe impairment of Na+/K+-homeostasis, due to cardiac glycoside-induced inhibition of active Na+/K+-transport. This, however, only occurs in the presence of toxic (receptor occupation ≥ 60%), but not in the presence of positive inotropic, non-toxic (receptor occupation 20–60%), ouabain concentrations. We conclude that the development of cardiac glycoside tolerance during long-term treatment in patients with heart failure should not occur with submaximal dose regimens, when toxic signs (arrhythmias) are absent.
Abbreviations
- CGP-12177:
-
(4-3-tert-butylamino-2-hydroxy-propoxy)-benzimidazol-2-one hydrochloride)
- HEPES:
-
N-2-hydroxyethylpiperazine-N′-2-ethanesulphonic acid
References
Arnold SB, Byrd R, Meister W, Melmon K, Cheitlin MD, Bristow JD, Parmley WW, Chatterjee K (1980) Long-term digitalis therapy improves left ventricular function in heart failure. New Engl J Med 303:1443–1448
Barry WH, Hasin Y, Smith TW (1985) Sodium pump inhibition, enhanced calcium exchange, and positive inotropic response in cultured heart cells. Circ Res 56:231–241
Biedert S, Barry WH, Smith TW (1979) Inotropic effects and changes in sodium and calcium contents associated with inhibition of monovalent cation active transport by ouabain in cultured myocardial cells. J Gen Physiol 74:479–494
Bluschke V, Bonn R, Greeff K (1976) Increase in the (Na+ + K+)-ATPase activity in heart muscle after chronic treatment with digitoxin or potassium deficient diet. Eur J Pharmac 37:189–191
Boardman L, Hume SP, Lamb JF, McCall D, Newton JP, Polson JM (1975) Genetic control of sodium pump density. In: Developmental and physiological correlates of cardiac muscle. Eds. Lieberman M, Sano T, Raven Press, New York, pp 127–138
Bonn R, Greeff K (1978) The effect of chronic administration of digitoxin on the activity of the myocardial (Na+ + K+)-ATPase in guinea-pigs. Arch Int Pharmacodyn Ther 233:53–64
Cameron JR, Ward JPT (1981) Adaptation of the sodium pump to chronic potassium lack. J Physiol 316:8P
Cumberbatch M, Zareian K, Davidson C, Morgan DB, Swaminathan R (1981) The early and late effects of digoxin treatment on the sodium transport, sodium content and Na+ + K+-ATPase of erythrocytes. Br J Clin Pharmacol 11:565–570
Davidson C, Gibson D (1973) Clinical significance of positive inotropic action of digoxin in patients with left ventricular disease. Br Heart J 35:970–976
Dobbs SM, Kenyonk WI, Dobbs RJ (1977) Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. Br Med J 1:749–752
Erdmann E, Bolte H-D, Lüderitz B (1971) The (Na+ + K+)-ATPase activity of guinea pig heart muscle in potassium deficiency. Arch Biochem Biophys 145:121–125
Erdmann E, Krawietz W (1977) Increased number of ouabain binding sites in human erythrocyte membranes in chronic hypokalaemia. Acta Biol Med Germ 36:879–883
Erdmann E, Krawietz W, Koch M (1979) Cardiac glycoside receptors in disease: the number of ouabain binding sites in human erythrocytes is subject of regulation. In: Na, K-ATPase, Structure and Kinetics. (Eds.: Skou JG, Norby JG), Academic Press, London pp 517–524
Erdmann E (1981) Influence of cardiac glycosides on their receptor. In: Greeff K (ed.) Cardiac Glycosides. Springer, Berlin Heidelberg New York (Handbook of Experimental Pharmacology, Vol. 56/I, pp 337–380)
Erdmann E, Krawietz W, Werdan K (1983) Gibt es Rezeptorveränderungen unter Langzeitwirkung von Digitalis? In: Digitalistherapie heute. Herausgeber: H. Gillmann und L. Storstein. Verlag für angewandte Wissenschaften, München pp 5–9
Erdmann E, Brown L (1983) The cardiac glycoside-receptor system in the human heart. Eur Heart J 4: Suppl. A pp 61–65
Erdmann E (1984) Stellenwert der Herzglykoside in der Therapie der chronischen Herzinsuffizienz, Klin Wochenschr 62:507–511
Erdmann E, Werdan K, Krawietz W (1984) Influence of digitalis and diuretics on ouabain binding sites on human erythrocytes. Klin Wochenschr 62:87–92
Fleg JL, Gottlieb SH, Lakatta EG (1982) Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. Am J Med 73:244–250
Ford AR, Aronson JK, Grahame-Smith DG, Carver JG (1979) The acute changes seen in cardiac glycoside receptor sites, rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy. Br J Clin Pharmacol 8:135–142
Gardner JD, Kiino DR (1973) Ouabain binding and cation transport in human erythrocytes. J Clin Invest 52:1845–1851
Grahame-Smith DG (1985) Pharmacological adaptive responses occurring during drug therapy and in disease. Trends Pharmac Sci 6:38–41
Isenberg G (1984) Contractility for isolated bovine ventricular myocytes is enhanced by intracellular injection of cardioactive glycosides. Evidence for an intracellular mode of action. In: Erdmann E (ed.) Cardiac glycoside receptors and positive inotropy — Evidence for more than one receptor? Steinkopff Verlag, Darmstadt (Basic Res Cardiol 79 (Suppl):56–71)
Kazazoglou T, Renaud JF, Rossi B, Lazdunski M (1983) Two classes of ouabain receptors in chick ventricular cardiac cells and their relation to (Na+ + K+)-ATPase inhibition, intracellular Na+ accumulation, Ca2+-influx, and cardiotonic effect. J Biol Chem 258:12163–12170
Kim D, Marsh JD, Barry WH, Smith TW (1984) Effects of growth in low potassium medium or ouabain on membrane Na, K-ATPase, cation transport and contractility in cultured chick heart cells. Circ Res 55:39–48
Kim D, Barry WH, Smith TW (1984) Kinetics of ouabain binding and changes in cellular sodium content,42K+-transport and contractile state during ouabain exposure in cultured chick heart cells. J Pharm Exp Therap 231:326–333
Koidl B, Tritthart HA (1980) The effects of ouabain on the electrical and mechanical activities of embryonic chick heart cells in culture. J Mol Cell Cardiol 12:663–673
Ku DD, Akera T, Brody T, Weaver LC (1977) Chronic digoxin treatment on canine myocardial Na++K+-ATPase. Naunyn-Schmiedeberg's Arch Pharmacol 301:39–47
Lee DC-S, Johnson RA, Bingham JB, Leahy M, Dinsmore RE, Goroll AB, Newell JB, Strauss HW, Haber E (1982) Heart failure in outpatients. A randomized trial of digoxin versus placebo. New Engl J Med 306:699–705
Lindsay R, Parker JLW (1976) Rat hepatic sodium plus potassium ion-dependent adenosine triphosphatase after treatment with digoxin and thyroxine. Clin Sci Mol Med 50:329–332
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Malini PL, Strocchi E, Marata AM, Ambrosioni E (1984) Digitalis ‘receptors’ during chronic digoxin treatment. Clin Exp Pharmacol Physiol 11:285–289
McHaffie S, Purcell H, Mitchell-Heggs P, Guz A (1978) The clinical value of digoxin in patients with heart failure and sinus rhythm. Q J Med 47:401–419
Nechay BR, Jackson RE, Ziegler MG, Neldon SL, Thompson JD (1981) Effects of chronic digitalization on cardiac and renal Na++K+-dependent adenosine triphosphatase activity and circulating catecholamines in the dog. Circ Res 49:655–660
Noble D (1980) Mechanism of action of therapeutic levels of cardiac glycosides. Cardiovasc Res 14:495–514
Pollack LR, Tate EH, Cook JS (1981) Na++K+-ATPase in HeLa cells after prolonged growth in low K+ or ouabain. J Cell Physiol 106:85–97
Porzig H, Becker C, Reuter H (1982) Competitive and non-competitive interactions between specific ligands and beta-adrenoceptors in living cardiac cells. Naunyn-Schmiedeberg's Arch Pharmacol 321:89–99
Scatchard G (1949) The attractions of protein for small molecules and ions. Ann NY Acad Sci 51:660–672
Staiger J, Späth J, Dickhuth H-H, Keul J (1983) Influence of low-dose digitoxin (0.07 mg) on left ventricular contractility in chronic heart failure (stages II–III). Z Kardiol 72:448–455
Vassalle M, Lee CO (1984) The relationship among intracellular sodium activity, calcium, and strophanthidin in canine cardiac Purkinje fibers. J Gen Physiol 83:287–303
Vogel R, Frischknecht J, Steele P (1977) Short- and long-term effects of digitalis on resting and post hand grip hemodynamics in patients with coronary artery disease. Am J Cardiol 40:171–176
Werdan K, Bauriedel G, Bozsik M, Krawietz W, Erdmann E (1980) Effects of vanadate in cultured rat heart muscle cells. Vanadate transport, intracellular binding and vanadate-induced changes in beating and in active cation flux. Biochim Biophys Acta 597:364–383
Werdan K, Bauriedel G, Fischer B, Krawietz W, Erdmann E, Schmitz W, Scholz H (1982) Stimulatory (insulin-mimetic) and inhibitory (ouabain-like) action of vanadate on potassium uptake and cellular sodium and potassium in heart cells in culture. Biochim Biophys Acta 687:79–93
Werdan K, Zwißler B, Wagenknecht B, Krawietz W, Erdmann E (1983) Quantitative correlation of cardiac glycoside binding to its receptor and inhibition of the sodium pump in chicken heart cells in culture. Biochem Pharmacol 32:757–760
Werdan K, Wagenknecht B, Zwißler B, Brown L, Krawietz W, Erdmann E (1984) Cardiac glycoside receptors in cultured heart cells-I. Characterization of one single class of high affinity receptors in heart muscle cells from chick embryos. Biochem Pharmacol 33:55–70
Werdan K, Reithmann C, Krawietz W, Erdmann E (1984) Chronic exposure to toxic but not to “therapeutic” concentrations of ouabain increases cardiac glycoside receptors in cardiac muscle cells from chicken embryos. Biochem Pharmacol 33:2337–2340
Werdan K, Schneider G, Krawietz W, Erdmann E (1984) Chronic exposure to low K+ increases cardiac glycoside receptors in cultured cardiac cells: different responses of cardiac muscle and non-muscle cells from chicken embryos. Biochem Pharmacol 33:1161–1164
Werdan K (1984) Herzglykosid-Rezeptoren der intaken Herzmuskelzelle — Eigenschaften und deren experimentelle Beeinflussung. Habilitationsschrift, Universität München
Werdan K, Schneider G, Reithmann C, Krawietz W, Erdmann E (1984) Ouabain treatment and chronic K+ depletion increase the number of cardiac glycoside receptors. Eur Heart J 5 (Suppl. I):192
Whittacker J, Swaminathan R (1983) The effect of chronic digoxin administration on the Na++K+-ATPase activity in the pig. IRCS Med Sci 11:846
Wilkins RR, Kendall MJ, Wade OL (1985) William Withering and digitalis, 1785 to 1985. Br Med J 290:7–8
Author information
Authors and Affiliations
Additional information
Some of the results were presented at the “IXth European Congress of Cardiology”, July 1984, Düsseldorf, Germany [49]
Rights and permissions
About this article
Cite this article
Werdan, K., Reithmann, C. & Erdmann, E. Cardiac glycoside tolerance in cultured chicken heart muscle cells — A dose-dependent phenomenon. Klin Wochenschr 63, 1253–1264 (1985). https://doi.org/10.1007/BF01738450
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01738450